Articles for tag: aperture, clozapine, delay, diagnosis, efficacy, impact, medication, neurobiological, psychiatry, response, treatment, treatment resistance, TRS

The Narrowing Temporal Apertures for Clozapine in Treatment-Resistant Schizophrenia

This article has not been peer reviewed. It proposes a conceptual model supported by converging observational evidence and clinical reasoning. Treatment-resistant schizophrenia affects approximately 20–30% of individuals with schizophrenia. It is characterised by inadequate response to at least two adequate trials of different antipsychotics. Clozapine remains the only antipsychotic with robust evidence of benefit in this population and is recommended as first-line treatment once treatment resistance has been identified.1 In clinical practice, clozapine initiation is frequently delayed — often by ...

Clozapine-Associated Cardiac Pathologies

Clozapine, an atypical antipsychotic medication, is widely recognised as the most effective treatment for individuals with treatment-resistant schizophrenia (TRS).1 Approved in 1989, its utilisation has grown, particularly for patients who have not responded adequately to other antipsychotic agents.3 Despite its superior therapeutic efficacy, clozapine carries a significant cautionary “black box warning” due to its association with rare but serious adverse effects, most notably agranulocytosis, but also considerable cardiovascular risks.5 It is important to note that, despite these risks, population-level studies ...

Clozapine – including lessons from the Coroner

Clozapine is a unique antipsychotic medication that plays a crucial role in treating severe mental health conditions. It is the only drug proven effective for treatment-resistant schizophrenia, offering hope to patients who have not responded to other treatments. See also: Treatment Resistant Schizophrenia. However, its use comes with strict monitoring requirements due to potential serious side effects, including risks to blood health and the heart. This article explores clozapine’s licenced and unlicenced uses, its historical development, and the protocols for ...

Schizophrenia and TRS

Schizophrenia is a widely understood and misunderstood mental health condition. Many mental health professionals believe they ‘know’ what schizophrenia is. Ideas ‘about delusions and hallucinations’ just scratch the surface, as will be seen when ICD-11 criteria are explored. Millions of pages of journals and books have been written on this topic over the last 30 years. This article could not possibly condense all the important aspects of schizophrenia to everyone’s satisfaction. Between higher specialist training and into the first 5 ...